PetMed Express, Inc. (PETS) |
|
21.52 0.37 (1.75%)
|
01-27 16:00 |
|
Open: |
21.15 |
Pre. Close: |
21.15 |
|
High:
|
21.5704 |
Low:
|
21.065 |
|
Volume:
|
271,914 |
Market Cap:
|
454(M) |
|
|
|
Technical analysis |
as of: 2023-01-27 4:47:01 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 25.19  One year: 29.42 |
| Support: |
Support1: 18.79 Support2: 17.07 |
| Resistance: |
Resistance1: 21.57 Resistance2: 25.19 |
| Pivot: |
19.63 |
| Moving Average: |
MA(5): 20.7 MA(20): 19.21
MA(100): 19.87 MA(250): 21.87  |
| MACD: |
MACD(12,26): 0.5 Signal(9): 0.2 |
| Stochastic oscillator: |
%K(14,3): 98.8 %D(3): 96.2 |
| RSI: |
RSI(14): 65.6 |
| 52-week: |
High: 29.53 Low: 17.07 |
| Average Vol(K): |
3-Month: 340 (K) 10-Days: 416 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ PETS ] has closed below upper band by 1.7%. Bollinger Bands are 62.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
21.58 - 21.65 |
21.65 - 21.72 |
|
Low:
|
20.87 - 20.95 |
20.95 - 21.04 |
|
Close:
|
21.38 - 21.5 |
21.5 - 21.63 |
|
Company Description |
|
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida. |
Headline News |
Sun, 29 Jan 2023
These 31 openly gay pets will melt your cold, dark heart - LGBTQ Nation
Sun, 29 Jan 2023
Mutty Paws Rescue treating burned 4-week-old puppy, needs donations - WPTV News Channel 5 West Palm
Sun, 29 Jan 2023
Pet Skunk Learning to Play with Kitten Sibling Is Both Fascinating and Adorable - Yahoo Life
Sun, 29 Jan 2023
Adoptable senior pup in Kentucky stuns in adorable JCPenney pet portraits - Fox News
Sat, 28 Jan 2023
Montclair Gets 'Better Cities For Pets' Designation - Baristanet
Sat, 28 Jan 2023
Robot Pets and VR Headsets Can Reduce Older Adults' Loneliness. So Why Don't They? - The Wall Street Journal
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Pharmaceutical Retailers |
| Shares Out. |
0 (M) |
| Shares Float |
21 (M) |
|
% Held by Insiders
|
1.936e+007 (%) |
|
% Held by Institutions
|
4.2 (%) |
|
Shares Short
|
4,110 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
2.203e+007 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
-58.91 |
|
Profit Margin (%)
|
205.5 |
|
Operating Margin (%)
|
5.9 |
|
Return on Assets (ttm)
|
7.2 |
|
Return on Equity (ttm)
|
7.2 |
|
Qtrly Rev. Growth
|
2.623e+008 |
|
Gross Profit (p.s.)
|
-5.09 |
|
Sales Per Share
|
19 |
|
EBITDA (p.s.)
|
1.32339e+008 |
|
Qtrly Earnings Growth
|
0.8 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
23 (M) |
Stock Valuations |
|
PE Ratio
|
0 |
|
PEG Ratio
|
-1 |
|
Price to Book value
|
-0.37 |
|
Price to Sales
|
1.13 |
|
Price to Cash Flow
|
1.86 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
4.4e+006 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
2021-11-18 |
|
Ex-Dividend Date
|
2021-11-04 |
|
Your Ad Here
|
|
